{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:06:39Z","timestamp":1793261199956,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012427","name":"Beijing Tiantan Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.canlet.2024.216834","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T12:53:17Z","timestamp":1711371197000},"page":"216834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["OH2 oncolytic virus: A novel approach to glioblastoma intervention through direct targeting of tumor cells and augmentation of anti-tumor immune responses"],"prefix":"10.1016","volume":"589","author":[{"given":"Yi","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aizhong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lairong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sipeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunna","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YaLi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2852-600X","authenticated-orcid":false,"given":"Binlei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7638-4395","authenticated-orcid":false,"given":"Wenbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.canlet.2024.216834_bib1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/neuonc\/noac198","article-title":"National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2024.216834_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cncr.33918","article-title":"Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system","volume":"128","author":"Gritsch","year":"2022","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.canlet.2024.216834_bib3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41582-019-0220-2","article-title":"Genetic and molecular epidemiology of adult diffuse glioma","volume":"15","author":"Molinaro","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.canlet.2024.216834_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2020.10.050","article-title":"Clinical practice guidelines for the management of adult diffuse gliomas","volume":"499","author":"Jiang","year":"2021","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.canlet.2024.216834_bib5","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.annonc.2021.03.197","article-title":"Oncolytic virus in gliomas: a review of human clinical investigations","volume":"32","author":"Carpenter","year":"2021","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.canlet.2024.216834_bib6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/mt.2009.73","article-title":"Herpes simplex virus oncolytic therapy for pediatric malignancies","volume":"17","author":"Friedman","year":"2009","journal-title":"Mol. Ther."},{"issue":"25","key":"10.1016\/j.canlet.2024.216834_bib7","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","article-title":"Talimogene Laherparepvec improves durable response rate in patients with advanced melanoma","volume":"33","author":"Andtbacka","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2024.216834_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11912-020-01007-5","article-title":"Current advances in immunotherapy for glioblastoma","volume":"23","author":"Mende","year":"2021","journal-title":"Curr. Oncol. Rep."},{"issue":"8","key":"10.1016\/j.canlet.2024.216834_bib9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/14712598.2019.1614557","article-title":"Oncolytic herpes simplex virus therapy for malignant glioma: current approaches to successful clinical application","volume":"19","author":"Hua","year":"2019","journal-title":"Expert Opin Biol Ther"},{"issue":"111","key":"10.1016\/j.canlet.2024.216834_bib10","first-page":"303","article-title":"Turning killer into cure -- the story of oncolytic herpes simplex viruses","volume":"20","author":"Zhang","year":"2015","journal-title":"Discov. Med."},{"issue":"3","key":"10.1016\/j.canlet.2024.216834_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093103","article-title":"A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activity","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"issue":"37","key":"10.1016\/j.canlet.2024.216834_bib12","doi-asserted-by":"crossref","first-page":"24672","DOI":"10.18632\/oncotarget.25122","article-title":"Stability and anti-tumor effect of oncolytic herpes simplex virus type 2","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget"},{"issue":"17","key":"10.1016\/j.canlet.2024.216834_bib13","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.7150\/thno.74075","article-title":"Single-cell transcriptomics of peripheral blood reveals anti-tumor systemic immunity induced by oncolytic virotherapy","volume":"12","author":"Wu","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.canlet.2024.216834_bib14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12916-022-02574-z","article-title":"SIRPalpha antibody combined with oncolytic virus OH2 protects against tumours by activating innate immunity and reprogramming the tumour immune microenvironment","volume":"20","author":"Kong","year":"2022","journal-title":"BMC Med."},{"issue":"22","key":"10.1016\/j.canlet.2024.216834_bib15","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1002\/cam4.4772","article-title":"A novel oncolytic virus induces a regional cytokine storm and safely eliminates malignant ascites of colon cancer","volume":"11","author":"Dong","year":"2022","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2024.216834_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.omto.2019.12.012","article-title":"oHSV2 can target murine colon carcinoma by altering the immune status of the tumor microenvironment and inducing antitumor immunity","volume":"16","author":"Zhang","year":"2020","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.canlet.2024.216834_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106581","article-title":"Transarterial viroembolization improves the therapeutic efficacy of immune-excluded liver cancer: three birds with one stone","volume":"187","author":"Cao","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.canlet.2024.216834_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002224","article-title":"Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I\/II clinical trial","volume":"9","author":"Zhang","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"1A","key":"10.1016\/j.canlet.2024.216834_bib19","first-page":"A68","article-title":"The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Contemp. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2024.216834_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","author":"Consortium","year":"2013","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.canlet.2024.216834_bib21","first-page":"1","article-title":"Chinese glioma genome Atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients","volume":"19","author":"Zhao","year":"2021","journal-title":"Dev. Reprod. Biol."},{"issue":"2","key":"10.1016\/j.canlet.2024.216834_bib22","first-page":"89","article-title":"Construction of a new oncolytic virus oHSV2hGM-CSF and its anti-tumor effects","volume":"34","author":"Shi","year":"2012","journal-title":"Chin. J. Oncol."},{"key":"10.1016\/j.canlet.2024.216834_bib23","unstructured":"Y. Zheng, L.R. Song, X.Y. Xu, et al., Construction and application of the human glioblastoma cell line Y1203, J. Cap. Med. Univ. 44 (5) 733\u2013740."},{"issue":"12","key":"10.1016\/j.canlet.2024.216834_bib24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.canlet.2024.216834_bib25","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"issue":"43","key":"10.1016\/j.canlet.2024.216834_bib26","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.canlet.2024.216834_bib27","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"issue":"5","key":"10.1016\/j.canlet.2024.216834_bib28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2024.216834_bib29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/978-1-62703-059-5_22","article-title":"Principal components analysis","volume":"930","author":"Groth","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"12","key":"10.1016\/j.canlet.2024.216834_bib30","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.canlet.2024.216834_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP","volume":"37","author":"Becht","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.canlet.2024.216834_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giy083","article-title":"Clustering trees: a visualization for evaluating clusterings at multiple resolutions","volume":"7","author":"Zappia","year":"2018","journal-title":"GigaScience"},{"key":"10.1016\/j.canlet.2024.216834_bib33","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","article-title":"UCell: robust and scalable single-cell gene signature scoring","volume":"19","author":"Andreatta","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"11","key":"10.1016\/j.canlet.2024.216834_bib34","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.canlet.2024.216834_bib35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf."},{"issue":"1","key":"10.1016\/j.canlet.2024.216834_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.chom.2007.06.005","article-title":"Alternative entry receptors for herpes simplex virus and their roles in disease","volume":"2","author":"Taylor","year":"2007","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.canlet.2024.216834_bib37","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s41467-021-21407-w","article-title":"Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages","volume":"12","author":"Ochocka","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.canlet.2024.216834_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112197","article-title":"Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of glioma","volume":"42","author":"Rajendran","year":"2023","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.canlet.2024.216834_bib39","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41565-020-00843-7","article-title":"Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection","volume":"16","author":"Zhang","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"7","key":"10.1016\/j.canlet.2024.216834_bib40","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/annonc\/mdx169","article-title":"Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma","volume":"28","author":"Qazi","year":"2017","journal-title":"Ann. Oncol."},{"issue":"14","key":"10.1016\/j.canlet.2024.216834_bib41","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2017.75.8219","article-title":"Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma","volume":"36","author":"Lang","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.216834_bib42","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/978-1-4614-3146-6_14","article-title":"Active immunotherapy: oncolytic virus therapy using HSV-1","volume":"746","author":"Todo","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"issue":"10","key":"10.1016\/j.canlet.2024.216834_bib43","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s00262-022-03172-x","article-title":"Enhancement of CD70-specific CAR T treatment by IFN-gamma released from oHSV-1-infected glioblastoma","volume":"71","author":"Zhu","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.canlet.2024.216834_bib44","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s40259-022-00553-7","article-title":"Teserpaturev\/G47Delta: first approval","volume":"36","author":"Frampton","year":"2022","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.canlet.2024.216834_bib45","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1038\/s41467-022-31262-y","article-title":"A phase I\/II study of triple-mutated oncolytic herpes virus G47\u0394 in patients with progressive glioblastoma","volume":"13","author":"Todo","year":"2022","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.canlet.2024.216834_bib46","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41591-022-01897-x","article-title":"Intratumoral oncolytic herpes virus G47\u0394 for residual or recurrent glioblastoma: a phase 2 trial","volume":"28","author":"Todo","year":"2022","journal-title":"Nat Med"},{"issue":"7985","key":"10.1016\/j.canlet.2024.216834_bib47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41586-023-06623-2","article-title":"Clinical trial links oncolytic immunoactivation to survival in glioblastoma","volume":"623","author":"Ling","year":"2023","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.canlet.2024.216834_bib48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1462-5822.2004.00389.x","article-title":"Herpes simplex virus: receptors and ligands for cell entry","volume":"6","author":"Spear","year":"2004","journal-title":"Cell Microbiol."},{"issue":"3","key":"10.1016\/j.canlet.2024.216834_bib49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0092-8674(00)81363-X","article-title":"Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF\/NGF receptor family","volume":"87","author":"Montgomery","year":"1996","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.canlet.2024.216834_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32353-x","article-title":"Enhanced sensitivity of patient-derived pediatric high-grade brain tumor xenografts to oncolytic HSV-1 virotherapy correlates with nectin-1 expression","volume":"8","author":"Friedman","year":"2018","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.canlet.2024.216834_bib51","doi-asserted-by":"crossref","first-page":"11185","DOI":"10.1128\/JVI.75.22.11185-11195.2001","article-title":"Structural features of nectin-2 (HveB) required for herpes simplex virus entry","volume":"75","author":"Martinez","year":"2001","journal-title":"J. Virol."},{"issue":"30","key":"10.1016\/j.canlet.2024.216834_bib52","doi-asserted-by":"crossref","first-page":"21348","DOI":"10.18632\/oncotarget.25096","article-title":"Comparison of infectivity and spread between HSV-1 and HSV-2 based oncolytic viruses on tumor cells with different receptor expression profiles","volume":"9","author":"Fu","year":"2018","journal-title":"Oncotarget"},{"issue":"17","key":"10.1016\/j.canlet.2024.216834_bib53","doi-asserted-by":"crossref","first-page":"9695","DOI":"10.1128\/JVI.77.17.9695-9699.2003","article-title":"Differences in the N termini of herpes simplex virus type 1 and 2 gDs that influence functional interactions with the human entry receptor Nectin-2 and an entry receptor expressed in Chinese hamster ovary cells","volume":"77","author":"Zago","year":"2003","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.canlet.2024.216834_bib54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2005.09.016","article-title":"Different receptors binding to distinct interfaces on herpes simplex virus gD can trigger events leading to cell fusion and viral entry","volume":"344","author":"Spear","year":"2006","journal-title":"Virology"},{"issue":"Pt 3","key":"10.1016\/j.canlet.2024.216834_bib55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcancer.2022.05.003","article-title":"Therapy-induced shaping of the glioblastoma microenvironment: macrophages at play","volume":"86","author":"Erbani","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.canlet.2024.216834_bib56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.4720","article-title":"CD169 identifies an anti-tumour macrophage subpopulation in human hepatocellular carcinoma","volume":"239","author":"Zhang","year":"2016","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.canlet.2024.216834_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12967-017-1139-2","article-title":"Distinct patterns and prognostic values of tumor-infiltrating macrophages in hepatocellular carcinoma and gastric cancer","volume":"15","author":"Li","year":"2017","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.canlet.2024.216834_bib58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ccr.2006.11.021","article-title":"AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients","volume":"11","author":"Batchelor","year":"2007","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.canlet.2024.216834_bib59","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41590-019-0433-y","article-title":"Mechanisms of immunotherapy resistance: lessons from glioblastoma","volume":"20","author":"Jackson","year":"2019","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.canlet.2024.216834_bib60","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd.2016.178","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"15","author":"Kaufman","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"13","key":"10.1016\/j.canlet.2024.216834_bib61","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.128217","article-title":"Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma","volume":"4","author":"Wirsching","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.canlet.2024.216834_bib62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41525-019-0107-6","article-title":"Spontaneous mutations in the single TTN gene represent high tumor mutation burden","volume":"5","author":"Oh","year":"2020","journal-title":"NPJ Genom Med"},{"issue":"8","key":"10.1016\/j.canlet.2024.216834_bib63","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s00535-018-1432-8","article-title":"Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation","volume":"53","author":"Sanmartin-Salinas","year":"2018","journal-title":"J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.canlet.2024.216834_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112615","article-title":"IRS4 promotes the progression of non-small cell lung cancer and confers resistance to EGFR-TKI through the activation of PI3K\/Akt and Ras-MAPK pathways","volume":"403","author":"Hao","year":"2021","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.canlet.2024.216834_bib65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00401-018-1849-4","article-title":"Novel, improved grading system(s) for IDH-mutant astrocytic gliomas","volume":"136","author":"Shirahata","year":"2018","journal-title":"Acta Neuropathol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524002271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524002271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T02:27:37Z","timestamp":1713234457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524002271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":65,"alternative-id":["S0304383524002271"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216834","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OH2 oncolytic virus: A novel approach to glioblastoma intervention through direct targeting of tumor cells and augmentation of anti-tumor immune responses","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"216834"}}